ERBB2 and breast cancer: We believe that this subtype represents de-differentiated luminal breast cancers, since BCL2 expression had been preserved in most cases, an anti-apoptotic protein frequently expressed in luminal A and luminal B breast cancer but generally not in HER2 positive or TNBC tumors [12, 35].